Pancreatic steatosis and fibrosis: Quantitative assessment with preoperative multiparametric MR imaging

Radiology

Volumn 279, Issue 1, 2016, Pages 140-150

  Yoon, Jeong Hee ^a,b   Lee, Jeong Min ^a,b   Lee, Kyung Bun ^a   Kim, Sun Whe ^a   Kang, Mee Joo ^a   Jang, Jin Young ^a   Kannengiesser, Stephan ^c   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c SIEMENS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CYSTIC FIBROSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FAT FRACTION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS DISEASE; PANCREAS FISTULA; PANCREATIC STEATOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; VERY ELDERLY; FIBROSIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATIC DISEASES; PATHOLOGY; PREOPERATIVE PERIOD; PROCEDURES;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC DISEASES; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 84962858678     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142254     Document Type: Article

References (44)

1. Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician 2006;73(3):485-492.
2. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000; 232(6):786-795.
3. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreatico-duodenectomies. Ann Surg 2006;244(1):10-15.
4. Büchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003;138(12):1310-1314; discussion 1315.
5. Balcom JH 4th, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136(4):391-398.
6. Brient C, Regenet N, Sulpice L, et al. Risk factors for postoperative pancreatic fstuli-zation subsequent to enucleation. J Gastro-intest Surg 2012;16(10):1883-1887.
7. Butturini G, Daskalaki D, Molinari E, Sco-pelliti F, Casarotto A, Bassi C. Pancreatic fstula: defnition and current problems. J Hepatobiliary Pancreat Surg 2008;15(3): 247-251.
8. Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatecto-my fstula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 2008; 207(4):490-498.
9. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fstula: an international study group (ISGPF) defnition. Surgery 2005; 138(1):8-13.
10. Roberts KJ, Storey R, Hodson J, Smith AM, Morris-Stiff G. Pre-operative prediction of pancreatic fstula: is it possible? Pancreatol-ogy 2013;13(4):423-428.
11. Kirihara Y, Takahashi N, Hashimoto Y, et al. Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition. Ann Surg 2013; 257(3):512-519.
12. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fstula. Ann Surg 2007;246(6):1058-1064.
13. Lee SE, Jang J-Y, Lim C-S, et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fstula after pancreatoduodenec-tomy. Ann Surg 2010;251(5):932-936.
14. Watanabe H, Kanematsu M, Tanaka K, et al. Fibrosis and postoperative fstula of the pancreas: correlation with MR imaging fndings-preliminary results. Radiology 2014;270(3):791-799.
15. Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fbrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;37(6):630-639.
16. Hwang I, Lee JM, Lee KB, et al. Hepatic ste-atosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spec-troscopy. Radiology 2014;271(3):730-738.
17. Guiu B, Petit J-M, Loffroy R, et al. Quanti-fcation of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009;250(1):95-102.
18. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantifcation of liver fbrosis: preliminary experience. AJR Am J Roentgenol 2007;189(4):799-806.
19. Al Sharaf K, Ihse I, Dawiskiba S, Andrén-Sandberg å. Characteristics of the gland remnant predict complications after subtotal pan-createctomy. Dig Surg 1997;14(2):101-106.
20. Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fstula after pancre-aticoduodenectomy. Surgery 2010;148(1): 15-23.
21. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505.
22. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fstula and other complications after pancreaticoduodenectomy? results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232(3): 419-429.
23. Rosso E, Casnedi S, Pessaux P, et al. The role of "fatty pancreas" and of BMI in the occurrence of pancreatic fstula after pancreati-coduodenectomy. J Gastrointest Surg 2009; 13(10):1845-1851.
24. Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unen-hanced CT: pathologic correlation and clinical implications. Radiology 2014;271(1):104-112.
25. Wellner UF, Kayser G, Lapshyn H, et al. A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fstula pre-operatively. HPB (Oxford) 2010;12(10): 696-702.
26. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227(3):617-622.
27. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-845.
28. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26(3):200-205.
29. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010;18(4):841-847.
30. Li J, Xie Y, Yuan F, Song B, Tang C. Noninvasive quantifcation of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content. Pancreas 2011;40(2):295-299.
31. Al-Haddad M, Khashab M, Zyromski N, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 2009;38(6):672-675.
32. Yoon JH, Lee JM, Baek JH, et al. Evaluation of hepatic fbrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 2014;38(1):110-116.
33. Bali MA, Metens T, Denolin V, et al. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters. Radiology 2011;261(2):456-466.
34. Coenegrachts K, Van Steenbergen W, De Keyzer F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990-997.
35. Patel AG, Reber PU, Toyama MT, Ashley S W, Reber HA. Effect of pancreaticoje-junostomy on fbrosis, pancreatic blood fow, and interstitial pH in chronic pancreatitis: a feline model. Ann Surg 1999; 230(5):672-679.
36. Apte MV, Wilson JS. Mechanisms of pancreatic fbrosis. Dig Dis 2004;22(3):273-279.
37. Klauss M, Gaida MM, Lemke A, et al. Fi-brosis and pancreatic lesions: counterintuitive behavior of the diffusion imaging-derived structural diffusion coeffcient d. Invest Radiol 2013;48(3):129-133.
38. Nonomura Y, Yasumoto M, Yoshimura R, et al. Relationship between bone marrow cel-lularity and apparent diffusion coeffcient. J Magn Reson Imaging 2001;13(5):757-760.
39. Bülow R, Mensel B, Meffert P, Hernando D, Evert M, Kühn J-P. Diffusion-weighted magnetic resonance imaging for staging liver fbrosis is less reliable in the presence of fat and iron. Eur Radiol 2013;23(5):1281-1287.
40. Kim Z, Kim MJ, Kim JH, et al. Prediction of post-operative pancreatic fstula in pan-creaticoduodenectomy patients using preoperative MRI: a pilot study. HPB (Oxford) 2009;11(3):215-221.
41. Israel JS, Rettammel RJ, Leverson GE, et al. Does postoperative drain amylase predict pancreatic fstula after pancreatectomy? J Am Coll Surg 2014;218(5):978-987.
42. Allen PJ, Gönen M, Brennan MF, et al. Pa-sireotide for postoperative pancreatic fstula. N Engl J Med 2014;370(21):2014-2022.
43. Rahbour G, Siddiqui MR, Ullah MR, Gabe SM, Warusavitarne J, Vaizey CJ. A meta-analysis of outcomes following use of so-matostatin and its analogues for the management of enterocutaneous fstulas. Ann Surg 2012;256(6):946-954.
44. Tran TC, van 't Hof G, Kazemier G, et al. Pancreatic fbrosis correlates with exocrine pancreatic insuffciency after pancreatoduo-denectomy. Dig Surg 2008;25(4):311-318.